多参数MRI与PSMA联合MRI在前列腺癌前列腺内诊断中的比较:系统评价与Meta分析
该系统评价与Meta分析共纳入19项直接比较多参数MRI(mpMRI)与前列腺特异性膜抗原(PSMA)PET联合MRI(PSMA+MRI)的研究,评估两者检测前列腺内临床显著前列腺癌(csPCa)的效能。患者水平分析显示PSMA+MRI的汇总灵敏度高于mpMRI(96% vs 89%,P=0.04),特异度无显著差异(55% vs 50%,P=0.67)。作者结论为PSMA+MRI相比mpMRI具有更优的汇总灵敏度且特异度相似。
要点
- 患者水平PSMA+MRI检测csPCa的汇总灵敏度为96%,高于mpMRI的89%(P=0.04)。
- 患者水平PSMA+MRI汇总特异度为55%,mpMRI为50%,两者无显著差异(P=0.67)。
- 区域水平灵敏度PSMA+MRI为85%、mpMRI为71%(P=0.09),特异度分别为87%和90%(P=0.59)。
核心结论
- 在直接比较研究的Meta分析中,PSMA+MRI检测csPCa的汇总灵敏度优于mpMRI,特异度相似。
研究设计与样本
- 系统评价与Meta分析,检索相关数据库截至2023年11月,仅纳入直接比较mpMRI与PSMA+MRI(PET/MRI或PET/CT+mpMRI)的研究,共纳入19项研究。
- 采用随机效应模型估计每种方法的汇总灵敏度、特异度和曲线下面积。
主要发现
- 患者水平分析中,PSMA+MRI(9项研究)检测csPCa的灵敏度为96%(95%CI:92%,98%),mpMRI为89%(95%CI:81%,94%),P=0.04。
- 患者水平分析中,PSMA+MRI(4项研究)的特异度为55%(95%CI:31%-76%),mpMRI为50%(95%CI:44%-57%),P=0.67。
- 区域水平分析中,PSMA+MRI(10项研究)的灵敏度为85%(95%CI:74%-92%),mpMRI为71%(95%CI:58%-82%),P=0.09。
- 区域水平分析中,PSMA+MRI(4项研究)的特异度为87%(95%CI:76%-94%),mpMRI为90%(95%CI:82%-95%),P=0.59。
- 病灶水平灵敏度和特异度在两种方法间相似,汇总数据来自少于4项研究。
局限性
- 病灶水平灵敏度和特异度的汇总数据来自少于4项研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The aim of this study was to perform a head-to-head comparison of multiparametric MRI (mpMRI) and the combination of prostate-specific membrane antigen (PSMA) PET plus MRI (PSMA + MRI) for detecting intraprostatic clinically significant prostate cancer (csPCa). PATIENTS AND METHODS: Relevant databases were searched through November 2023. Only studies directly comparing mpMRI and PSMA + MRI (PET/MRI or PET/CT + mpMRI) were included. A meta-analysis with a random-effects model was used to estimate pooled sensitivity, specificity, and area under the curve for each approach. RESULTS: A total of 19 studies were included. On a patient-level analysis, PSMA + MRI had higher sensitivity (9 studies) than mpMRI for csPCa detection (96% [95% confidence interval (CI): 92%, 98%] vs 89% [95% CI: 81%, 94%]; P = 0.04). The patient-level specificity (4 studies) of PSMA + MRI was 55% (95% CI: 31%-76%) compared with 50% (95% CI: 44%-57%) of mpMRI ( P = 0.67). Region-level sensitivity (10 studies) was 85% (95% CI: 74%-92%) for PSMA + MRI and 71% (95% CI: 58%-82%) for mpMRI ( P = 0.09), whereas specificity (4 studies) was 87% (95% CI: 76%-94%) and 90% (95% CI: 82%-95%), respectively ( P = 0.59). Lesion-level sensitivity and specificity were similar between modalities with pooled data from less than 4 studies. CONCLUSIONS: PSMA + MRI had superior pooled sensitivity and similar specificity for the detection of csPCa compared with mpMRI in this meta-analysis of head-to-head studies.
引用
- Brondani Torri G, Antune Pereira P, Piovesan Wiethan C, et al. Comparison of Multiparametric MRI and the Combination of PSMA Plus MRI for the Intraprostatic Diagnosis of Prostate Cancer: A Systematic Review and Meta-Analysis. Clin Nucl Med. 2024. PMID: 38776063. doi:10.1097/RLU.0000000000005265
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。